These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20818494)

  • 1. The effects of atorvastatin on pulmonary arterial hypertension and expression of p38, p27, and Jab1 in rats.
    Gao YF; Zhu XD; Shi DM; Jing ZC; Li L; Ma D; Fan ZX; Li J; Wang YW; Wu BX
    Int J Mol Med; 2010 Oct; 26(4):541-7. PubMed ID: 20818494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
    Rakotoniaina Z; Guerard P; Lirussi F; Goirand F; Rochette L; Dumas M; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):195-206. PubMed ID: 17102939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.
    Rakotoniaina Z; Guerard P; Lirussi F; Rochette L; Dumas M; Goirand F; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Sep; 378(3):241-51. PubMed ID: 18542928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study.
    McMurtry MS; Bonnet S; Michelakis ED; Bonnet S; Haromy A; Archer SL
    Am J Physiol Lung Cell Mol Physiol; 2007 Oct; 293(4):L933-40. PubMed ID: 17675370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of atorvastatin and losartan on monocrotaline-induced pulmonary artery remodeling in rats.
    Xie L; Lin P; Xie H; Xu C
    Clin Exp Hypertens; 2010; 32(8):547-54. PubMed ID: 21091363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension.
    Satoh M; Satoh A
    J Pharm Pharm Sci; 2009 Feb; 11(2):118s-130s. PubMed ID: 19203474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin prevents dehydromonocrotaline-induced pulmonary hypertension in beagles.
    Chen D; Zhou D; Qian J; Chen F; Guan L; Dong L; Ge J
    Exp Lung Res; 2012 Sep; 38(7):333-43. PubMed ID: 22888849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats.
    Lin Z; Jiang Z; Huang X; Cai X; Wang H; Xie L
    Clin Exp Hypertens; 2017; 39(6):495-501. PubMed ID: 28628347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of atorvastatin and L-arginine treatments on electrical field stimulation-mediated relaxations in pulmonary arterial rings of monocrotaline-induced pulmonary hypertensive rats.
    Ozturk EI; Uma S
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):498-505. PubMed ID: 20729759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
    Li XL; Guan RJ; Li JJ
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9.
    Souza-Costa DC; Figueiredo-Lopes L; Alves-Filho JC; Semprini MC; Gerlach RF; Cunha FQ; Tanus-Santos JE
    Crit Care Med; 2007 Jan; 35(1):239-45. PubMed ID: 17133179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Panax notoginseng saponins improve monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting ADAM10/Notch3 signaling pathway].
    Zhang S; Tian YN; Song ZY; Wang XT; Wang XY; Xu JP; Yuan LB; Wang WT
    Sheng Li Xue Bao; 2023 Aug; 75(4):503-511. PubMed ID: 37583037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin.
    Laudi S; Trump S; Schmitz V; West J; McMurtry IF; Mutlak H; Christians U; Weimann J; Kaisers U; Steudel W
    Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L630-8. PubMed ID: 17575010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Aminosalicylic Acid Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats by Increasing the Expression of Nur77.
    Sun LY; Cai ZY; Pu J; Li J; Shen JY; Yang CD; He B
    Inflammation; 2017 Jun; 40(3):806-817. PubMed ID: 28213866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of atorvastatin on metabolic pattern of rats with pulmonary hypertension.
    Luo L; Wu J; Lin T; Lian G; Wang H; Gao G; Xie L
    Aging (Albany NY); 2021 Apr; 13(8):11954-11968. PubMed ID: 33886502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of panax notoginseng saponins on pulmonary vascular remodeling in rats with pulmonary hypertension and its mechanisms].
    Song ZY; Wang XY; Tian YN; Li ZL; Wang XT; Yuan LB; Wang WT
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Nov; 38(6):650-654. PubMed ID: 37308411
    [No Abstract]   [Full Text] [Related]  

  • 17. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
    Mei Y; Jin H; Tian W; Wang H; Wang H; Zhao Y; Zhang Z; Meng F
    Pulm Pharmacol Ther; 2011 Aug; 24(4):386-93. PubMed ID: 21396478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyanidin‑3‑O‑β‑glucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGF‑β1/p38 MAPK/CREB signaling pathway.
    Ouyang S; Chen W; Gaofeng Z; Changcheng L; Guoping T; Minyan Z; Yang L; Min Y; Luo J
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
    Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin attenuates involvement of RhoA/Rho-kinase pathway and NF-κB activation in hypoxic pulmonary hypertensive rats.
    Zhang Y; Dai L; Wu S; Chen P; Zhao S
    Chin Med J (Engl); 2014; 127(5):869-72. PubMed ID: 24571879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.